Logo image of MARR.MI

MARR SPA (MARR.MI) Stock Fundamental Analysis

BIT:MARR - Euronext Milan - IT0003428445 - Common Stock - Currency: EUR

9.64  +0.02 (+0.21%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MARR. MARR was compared to 26 industry peers in the Consumer Staples Distribution & Retail industry. MARR has only an average score on both its financial health and profitability. MARR has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

MARR had positive earnings in the past year.
In the past year MARR had a positive cash flow from operations.
Of the past 5 years MARR 4 years were profitable.
MARR had a positive operating cash flow in 4 of the past 5 years.
MARR.MI Yearly Net Income VS EBIT VS OCF VS FCFMARR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

The Return On Assets of MARR (5.28%) is better than 73.08% of its industry peers.
With a decent Return On Equity value of 18.22%, MARR is doing good in the industry, outperforming 73.08% of the companies in the same industry.
MARR has a better Return On Invested Capital (10.67%) than 69.23% of its industry peers.
MARR had an Average Return On Invested Capital over the past 3 years of 6.59%. This is below the industry average of 9.64%.
The last Return On Invested Capital (10.67%) for MARR is above the 3 year average (6.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.28%
ROE 18.22%
ROIC 10.67%
ROA(3y)3.25%
ROA(5y)2.51%
ROE(3y)11.13%
ROE(5y)8.54%
ROIC(3y)6.59%
ROIC(5y)5.15%
MARR.MI Yearly ROA, ROE, ROICMARR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

MARR's Profit Margin of 2.07% is in line compared to the rest of the industry. MARR outperforms 57.69% of its industry peers.
In the last couple of years the Profit Margin of MARR has declined.
MARR's Operating Margin of 3.49% is in line compared to the rest of the industry. MARR outperforms 57.69% of its industry peers.
In the last couple of years the Operating Margin of MARR has declined.
With a Gross Margin value of 7.89%, MARR is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of MARR has grown nicely.
Industry RankSector Rank
OM 3.49%
PM (TTM) 2.07%
GM 7.89%
OM growth 3Y-4.69%
OM growth 5Y-10.77%
PM growth 3Y-5.22%
PM growth 5Y-12.22%
GM growth 3Y2.34%
GM growth 5Y1.72%
MARR.MI Yearly Profit, Operating, Gross MarginsMARR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

5

2. Health

2.1 Basic Checks

MARR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for MARR has been reduced compared to 1 year ago.
Compared to 5 years ago, MARR has less shares outstanding
MARR has about the same debt/assets ratio as last year.
MARR.MI Yearly Shares OutstandingMARR.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MARR.MI Yearly Total Debt VS Total AssetsMARR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.94 indicates that MARR is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.94, MARR is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
The Debt to FCF ratio of MARR is 12.48, which is on the high side as it means it would take MARR, 12.48 years of fcf income to pay off all of its debts.
MARR's Debt to FCF ratio of 12.48 is on the low side compared to the rest of the industry. MARR is outperformed by 76.92% of its industry peers.
MARR has a Debt/Equity ratio of 0.95. This is a neutral value indicating MARR is somewhat dependend on debt financing.
The Debt to Equity ratio of MARR (0.95) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 12.48
Altman-Z 3.94
ROIC/WACC1.65
WACC6.45%
MARR.MI Yearly LT Debt VS Equity VS FCFMARR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

MARR has a Current Ratio of 1.64. This is a normal value and indicates that MARR is financially healthy and should not expect problems in meeting its short term obligations.
MARR has a Current ratio of 1.64. This is amongst the best in the industry. MARR outperforms 88.46% of its industry peers.
MARR has a Quick Ratio of 1.18. This is a normal value and indicates that MARR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MARR (1.18) is better than 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.18
MARR.MI Yearly Current Assets VS Current LiabilitesMARR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

MARR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.27%.
MARR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.05% yearly.
The Revenue has decreased by -0.32% in the past year.
Measured over the past years, MARR shows a small growth in Revenue. The Revenue has been growing by 4.24% on average per year.
EPS 1Y (TTM)-15.27%
EPS 3Y7.67%
EPS 5Y-8.05%
EPS Q2Q%-260.77%
Revenue 1Y (TTM)-0.32%
Revenue growth 3Y12.68%
Revenue growth 5Y4.24%
Sales Q2Q%-2.26%

3.2 Future

The Earnings Per Share is expected to grow by 11.54% on average over the next years. This is quite good.
Based on estimates for the next years, MARR will show a small growth in Revenue. The Revenue will grow by 3.62% on average per year.
EPS Next Y12.03%
EPS Next 2Y11.57%
EPS Next 3Y11.54%
EPS Next 5YN/A
Revenue Next Year3.05%
Revenue Next 2Y3.37%
Revenue Next 3Y3.97%
Revenue Next 5Y3.62%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MARR.MI Yearly Revenue VS EstimatesMARR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
MARR.MI Yearly EPS VS EstimatesMARR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

6

4. Valuation

4.1 Price/Earnings Ratio

MARR is valuated reasonably with a Price/Earnings ratio of 10.71.
Based on the Price/Earnings ratio, MARR is valued cheaper than 84.62% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.19, MARR is valued rather cheaply.
With a Price/Forward Earnings ratio of 11.87, the valuation of MARR can be described as very reasonable.
MARR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MARR is cheaper than 61.54% of the companies in the same industry.
MARR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.71
Fwd PE 11.87
MARR.MI Price Earnings VS Forward Price EarningsMARR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MARR indicates a somewhat cheap valuation: MARR is cheaper than 61.54% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MARR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 17.93
EV/EBITDA 6.83
MARR.MI Per share dataMARR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

MARR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.89
PEG (5Y)N/A
EPS Next 2Y11.57%
EPS Next 3Y11.54%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.05%, MARR is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.74, MARR pays a better dividend. On top of this MARR pays more dividend than 92.31% of the companies listed in the same industry.
MARR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 6.05%

5.2 History

The dividend of MARR decreases each year by -5.06%.
Dividend Growth(5Y)-5.06%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

MARR pays out 62.06% of its income as dividend. This is not a sustainable payout ratio.
DP62.06%
EPS Next 2Y11.57%
EPS Next 3Y11.54%
MARR.MI Yearly Income VS Free CF VS DividendMARR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M
MARR.MI Dividend Payout.MARR.MI Dividend Payout, showing the Payout Ratio.MARR.MI Dividend Payout.PayoutRetained Earnings

MARR SPA

BIT:MARR (5/30/2025, 1:57:34 PM)

9.64

+0.02 (+0.21%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)05-15 2025-05-15
Earnings (Next)08-04 2025-08-04
Inst Owners24.76%
Inst Owner ChangeN/A
Ins Owners50.42%
Ins Owner ChangeN/A
Market Cap641.35M
Analysts81.67
Price Target12.87 (33.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.05%
Yearly Dividend0.6
Dividend Growth(5Y)-5.06%
DP62.06%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.84%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE 10.71
Fwd PE 11.87
P/S 0.21
P/FCF 17.93
P/OCF 9.98
P/B 1.86
P/tB 3.64
EV/EBITDA 6.83
EPS(TTM)0.9
EY9.34%
EPS(NY)0.81
Fwd EY8.43%
FCF(TTM)0.54
FCFY5.58%
OCF(TTM)0.97
OCFY10.02%
SpS45.79
BVpS5.2
TBVpS2.65
PEG (NY)0.89
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.28%
ROE 18.22%
ROCE 15.27%
ROIC 10.67%
ROICexc 15.23%
ROICexgc 23.33%
OM 3.49%
PM (TTM) 2.07%
GM 7.89%
FCFM 1.17%
ROA(3y)3.25%
ROA(5y)2.51%
ROE(3y)11.13%
ROE(5y)8.54%
ROIC(3y)6.59%
ROIC(5y)5.15%
ROICexc(3y)9.5%
ROICexc(5y)7.64%
ROICexgc(3y)14.76%
ROICexgc(5y)12.13%
ROCE(3y)9.43%
ROCE(5y)7.37%
ROICexcg growth 3Y-2.5%
ROICexcg growth 5Y-13.81%
ROICexc growth 3Y0.65%
ROICexc growth 5Y-11.99%
OM growth 3Y-4.69%
OM growth 5Y-10.77%
PM growth 3Y-5.22%
PM growth 5Y-12.22%
GM growth 3Y2.34%
GM growth 5Y1.72%
F-Score5
Asset Turnover2.56
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF 12.48
Debt/EBITDA 2.55
Cap/Depr 128.06%
Cap/Sales 0.93%
Interest Coverage 250
Cash Conversion 49.95%
Profit Quality 56.8%
Current Ratio 1.64
Quick Ratio 1.18
Altman-Z 3.94
F-Score5
WACC6.45%
ROIC/WACC1.65
Cap/Depr(3y)107.37%
Cap/Depr(5y)94.25%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.27%
EPS 3Y7.67%
EPS 5Y-8.05%
EPS Q2Q%-260.77%
EPS Next Y12.03%
EPS Next 2Y11.57%
EPS Next 3Y11.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.32%
Revenue growth 3Y12.68%
Revenue growth 5Y4.24%
Sales Q2Q%-2.26%
Revenue Next Year3.05%
Revenue Next 2Y3.37%
Revenue Next 3Y3.97%
Revenue Next 5Y3.62%
EBIT growth 1Y-13.21%
EBIT growth 3Y7.4%
EBIT growth 5Y-6.98%
EBIT Next Year52.54%
EBIT Next 3Y22.77%
EBIT Next 5YN/A
FCF growth 1Y-12.98%
FCF growth 3Y-31.25%
FCF growth 5Y-12.02%
OCF growth 1Y-5.16%
OCF growth 3Y-19.18%
OCF growth 5Y-3.88%